Application no. and date | 01935126.1 (espacenet) (Federated) (European Patent Register), 20010508 | Patent/reg. no. and date | DK/EP 1280520, 20140924 | Publication date | 20030205 | Priority no. and date | US 568818, 20000510, US 208896 P, 20000602, US 216621 P, 20000707 | EP pub. no. and date |
EP 1280520 20030205 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35
4002 Basel, CH | Applicant ref. no. | SH/GP/149761 | Inventor | RIESS, Jean, G., Les Giaines
F-06950 Falicon, FR, SCHUTT, Ernest, G., 12139 Ragweed Street
San Diego, CA 92129, US, DELLAMARY, Luis, A., 838 Redberry Court
San Marcos, CA 92069-1846, US, TARARA, Thomas, E., 1233 Paloma Avenue
Burlingame, CA 94010, US, WEERS, Jeffry, G., 432 Coronado Avenue
Half Moon Bay, CA 94019, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 9/127 (2006.01) , A61K 9/16 (2006.01) | Title | Phospholipid-baserede pulvere til medikamentafgivelse | Int. application no. | US2001014703 | Int. publication no. | WO2001085136 | Related patent (certificate) | CA 2015 00017 | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|